SciClone Pharmaceuticals Switzerland GmbH
- Sector unverified
- Rank 323 / 334
SciClone Pharmaceuticals Switzerland GmbH is recorded by Swissmedic as the authorisation holder for 1 human medicine, which places it 323 of 334 authorisation holders. Its portfolio is mostly in the Synthetika category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 1 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
SciClone Pharmaceuticals Switzerland GmbH is recorded by Swissmedic as the authorisation holder for 1 human medicine. The table shows 1 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
1 of 1 authorisation
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Eotriz 4 mg/5 ml | 67960 | B | M05BA08 | 2020-06-17 |
Frequently asked questions
How many medicines does SciClone Pharmaceuticals Switzerland GmbH have authorised in Switzerland?
SciClone Pharmaceuticals Switzerland GmbH is recorded by Swissmedic as the authorisation holder for 1 human medicine (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is SciClone Pharmaceuticals Switzerland GmbH based?
We have no confirmed Swiss address for SciClone Pharmaceuticals Switzerland GmbH. We add it as soon as the commercial register or the company confirms it.
Is SciClone Pharmaceuticals Switzerland GmbH a Swissmedic authorisation holder?
Yes. SciClone Pharmaceuticals Switzerland GmbH appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.